References
- FACT-JACIE International Standards for Hematopoietic Cellular Therapy. Product Collection, Processing, and Administration. Eight edition. https://www.ebmt.org/jacie-standards; last access date January 20, 2023.
- P. Wuchter, Processing, Cryopreserving and Controlling the Quality of HSCs, in The EBMT Handbook Hematopoietic Stem Cell Transplantation and Cellular Therapies (Eds. E. Carreras, C. Dufour, M. Mohtyand, N. Krögel), European Society for Blood and Marrow Transplantation 2019, pp.127–130.
- European Society for Blood and Marrow Transplantation. Coronavirus disease COVID-19: EBMT recommendations update April 21, 2020; https://www.ebmt.org/sites/default/files/2020-04/EBMT_COVID-19-guidelines_v.7.1%282020-04-21%29.pdf; last access date January 12, 2023.
- National Marrow Donor Program: BeTheMatch. Donor Product Cryopreservation: updated March 23, 2020; https://www.ebmt.org/sites/default/files/2020-04/EBMT_COVID-19-guidelines_v.7.1%282020-04-21%29.pdf; last access date January 12, 2023.
- K. Hornberger, G. Yu, D. McKenna and A. Hubel, Cryopreservation of hematopoietic stem cells: Emerging assays, cryoprotectant agents, and technology to improve outcomes, Transfus. Med. Hemother. 46(3) (2019) 188–196; https://doi.org/10.1159/000496068
- V. Fisher, H. Khuu, V. David-Ocampo, K. Byrne, S. Pavletic, M. Bishop, D. H. Fowler, A. J. Barrett and D. F. Stroncek, Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation, Transfusion 54(4) (2014) 1088–1092; https://doi.org/10.1111/trf.12428
- C. Berens, A. Heine, J. Müller, S. A. Held, K. Mayer, P. Brossart, J. Oldenburg, B. Pötzsch, D. Wolf and H. Rühl, Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products, Cytotherapy 18(10) (2016) 1325–1331; https://doi.org/10.1016/j.jcyt.2016.06.014
- H. Yang, J. P. Acker, M. Cabuhat and L. E. McGann, Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation, Bone Marrow Transplant. 32(10) (2003) 1021–1026; https://doi.org/10.1038/sj.bmt.1704247
- International Organization for Standardization (ISO). EN ISO 15189 – Medical laboratories – Requirements for quality and competence, 4th ed, Geneva, Switzerland: ISO; 2022.
- R. Gomez-Rioja, A. Von Meyer, M. Cornes, S. Costelloe, P. Vermeersch, A. M. Simundic, M. Nybo, G. S. Baird, G. B. B. Kristensen and J. Cadamuro, European Federation of Clinical Chemistry, Laboratory Medicine (EFLM) Working Group Preanalytical Phase (WG-PRE) Recommendation for the design of stability studies on clinical specimens, Clin. Chem. Lab. Med. 2023; Epub ahead of print; https://doi.org/10.1515/cclm-2023-0221
- J. W. Gratama, J. Kraan, M. Keeney, D. R. Sutherland, V. Granger and D. Barnett, Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study, Cytotherapy 5(1) (2003) 55–65; https://doi.org/10.1080/14653240310000083
- B. Mfarrej, J. Gaude, J. Couquiaud, B. Calmels, C. Chabannon and C. Lemarie, Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products, Cytotherapy 23(1) (2021) 77–87; https://doi.org/10.1016/j.jcyt.2020.06.005
- Y. H. Lee, H. Koh, E. Nam and Y. J. Kim, Cryopreserved cord blood mononuclear cells in DMSO are healthy for at least 6 hours after thawing, Transfus. Apher. Sci. 59(1) (2020) Article ID 102603; https://doi.org/10.1016/j.transci.2019.06.028
- L. J. Fry, S. Querol, S. G. Gomez, S. McArdl, R. Rees and J. A. Madrigal, Assessing the toxic effects of DMSO on cord blood to determine exposure time limits and the optimum concentration for cryopreservation, Vox Sang. 109(2) (2015)181–190; https://doi.org/10.1111/vox.12267
- L. Huang, G. Q. Song, Y. Wu, Y. J. Wang and Z. M. Sun, Optimal length of time of cryopreserved umbilical cord blood infusion after thawing, Hematology 19(2) (2014) 73–99; https://doi.org/10.1179/1607845413Y.0000000101
- Z. Shu, S. Heimfeld and D. Gao, Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion, Bone Marrow Transplant. 49(4) (2014) 469–476; https://doi.org/10.1038/bmt.2013.152
- J. Valtola, V. Varmavuo, A. Ropponen, A. Nihtinen, A. Partanen, K. Vasala, P. Lehtonen, K. Penttilä, M. Pyörälä, T. Kuittinen, R. Silvennoinen, T. Nousiainen, J. Pelkonen, P. Mäntymaa and E. Jantunen. Blood graft cellular composition and posttransplant recovery in non-Hodgkin’s lymphoma patients mobilized with or without plerixafor: a prospective comparison, Transfusion 55 (10) (2015) 2358–2368; https://doi.org/10.1111/trf.13170.2015; 55:2358-68
- A. Turunen, A. Partanen, J. Valtola, A. Ropponen, T. Siitonen, O. Kuittinen, H. Kuitunen, M. Putkonen, M. Sankelo, L. Keskinen, E. R. Savolainen, M. Pyörälä, T. Kuittinen, R. Silvennoinen, K. Penttilä, A. Sikiö, K. Vasala, P. Mäntymaa, J. Pelkonen, V. Varmavuo, E. Jantunen, CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin’s lymphoma patients: results of the prospective multicenter GOA study, Transfusion 60 (7) (2020) 1519–1528; https://doi.org/10.1111/trf.15820
- C. C. Pedrosa de Lira de Morais, J. Dias Alves Pint, K. Wagner de Souza, M. Izu, L. Fernando da Silva Bouzas and F. Henrique Paraguassú-Braga, Validation of the single-platform ISHAGE protocol for enumeration of CD34+ hematopoietic stem cells in umbilical cord blood in a Brazilian center, Hematol. Transfus. Cell Ther. 44(1) (2022) 49–55; https://doi.org/10.1016/j.htct.2020.09.151
- J. Fernandez-Sojo, R. Horton, J. Cid, C. Azqueta, A. Garcia-Buendia, E. Valdivia, L. Martorell, N. Rubio-Lopez, M. Codinach, G. Aran, J. Marsal, A. Mussetti, R. Martino, C. Diaz-de-Heredia, C. Ferra, D. Valcarcel, M. Linares, A. Ancochea, E. García-Rey, N. García-Muñoz, L. Medina, E. Carreras, J. Villa, M. Lozano, D. Gibson and S. Querol, Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry, Bone Marrow Transplant. 57(10) (2022)1531–1538; https://doi.org/10.1038/s41409-022-01750-2
- G. Fritsch, N. Frank, J. Dmytrus, C. Frech, H. Pichler, V. Witt, R. Geyeregger, D. Scharner, D. Trbojevic, E. Zipperer, D. Printz and N. Worel, Relevance of flow cytometric enumeration of post-thaw leucocytes: influence of temperature during cell staining on viable cell recovery, Vox Sang. 111(12) (2016) 187–196; https://doi.org/10.1111/vox.12398